ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2018

Jan 17, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2018-01-04

Reporting Person: Makker Gotham (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1331486	Indirect

Footnotes

F1: All numbers give effect to the 1:4 reverse stock split effected by the Issuer on January 4, 2018.

F2: The securities reported herein may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group.